Drug Shortage Report for ACH-ALENDRONATE
Report ID | 213617 |
Drug Identification Number | 02381494 |
Brand name | ACH-ALENDRONATE |
Common or Proper name | ALENDRONATE |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-12-12 |
Estimated end date | 2023-12-21 |
Actual end date | 2023-12-21 |
Shortage status | Resolved |
Updated date | 2023-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-12-22 | French | Compare |
v3 | 2023-12-22 | English | Compare |
v2 | 2023-12-15 | French | Compare |
v1 | 2023-12-15 | English | Compare |
Showing 1 to 4 of 4